WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER Patent applications |
Patent application number | Title | Published |
20150218229 | Methods and Peptides for Preventing and Treating A BCR-ABL and a C-ABL Associated Disease - The invention provides a combination of an isolated peptide or peptidomimetic that includes the sequence of SEQ ID NO: 1 or a homolog thereof, and an isolated peptide or peptidomimetic that includes the sequence of SEQ ID NO: 2. The invention also provides a method of treating a BCR-ABL associated disease or a c-ABL associated disease in a subject. The method is based on the use of the aforementioned combination of one or more isolated peptides or peptidomimetics. | 08-06-2015 |
20150188191 | 1,2,4-THIADIAZINANE-3,5-DIONE-1,1-DIOXIDE DERIVATIVES, PRODUCTION AND USE THEREOF - The present invention provides a compound with a general formula (I) | 07-02-2015 |
20150105278 | METHODS OR RISK ASSESSMENT OF PML AND RELATED APPARATUS - The invention provides a method of assessing the risk of occurrence of progressive multifocal leukoencephalopathy (PML) in a subject as well as a method of stratifying a subject undergoing VLA-4 blocking agent treatment for suspension of VLA-4 blocking agent treatment. These methods comprise detecting the level of L-selectin (CD62L) and optionally LFA-1 expressing T cells in a sample from the subject. | 04-16-2015 |
20140357842 | YERSINIA OUTER PROTEIN M (YOPM) IN THE TREATMENT OF PSORIASIS - The present invention relates to the use of Yersinia outer protein M (YopM)in the prevention and/or treatment of psoriasis by cutaneous, intradermalor subcutaneous administration. In particular, the present invention relates to the use of YopM in the treatment of plaque psoriasis, guttate psoriasis, inverse psoriasis, pustular psoriasis, erythrodermic psoriasis, arthritis psoriasis. | 12-04-2014 |
20140323394 | TRIPEPTIDE KDPT FOR ANTIAPOPTOTIC TREATMENT - The present invention is related to the tripeptide (I)Lys-(d)Pro-(I)Thr (KdPT) or pharmaceutically acceptable salts thereof for therapeutic, prophylactic therapeutic or cosmetic treatment of a disease with increased apoptosis, wherein the treatment has an anti-apoptotic effect. The present invention is also related to the use of KdPT or pharmaceutically acceptable salts thereof for the manufacture of a pharmaceutical or cosmetic composition for an anti-apoptotic treatment of disorders that are related with increased apoptosis. | 10-30-2014 |
20140170067 | NEW LIGANDS FOR TARGETING OF S1P RECEPTORS FOR IN VIVO IMAGING AND TREATMENT OF DISEASES - The present invention relates to novel compounds of formulae (I) and (II) which are useful in the prevention, treatment and diagnosis, in vivo diagnosis of diseases or disorders related to S1P receptors, in particular, in diseases which are connected to the regulatory function of sphingosine-1-phosphate (S1P) and its analogues, such as inflammation, pain, autoimmune diseases and cardiovascular diseases. | 06-19-2014 |
20140088307 | Platinum Complexes and Their Use - The invention relates to platinum complexes and their use in biomedical applications, like in vitro and in vivo imaging and cell staining. The present invention provides new materials and their use as imaging agent. The formation of luminescent aggregates can allow a switch of the emission leading to a dynamic label and on the formation of soft assemblies, which, in some cases, are even more emissive than the isolated corresponding species | 03-27-2014 |
20140080187 | SERINOL PRODUCTION IN GLYCEROL CATABOLISM DEFICIENT ESCHERICHIA COLI STRAINS - The invention is about | 03-20-2014 |
20130204011 | PYRAZOLE SYNTHESIS BY COUPLING OF CARBOXYLIC ACID DERIVATIVES AND ENAMINES - A method of synthesizing Pyrazoles by means of the oxidative conversion of Enamines with suitable N-containing carboxylic acid derivatives in the presence of copper ions and 2-picolinic acid derivatives is provided. | 08-08-2013 |
20130041349 | SUBSTITUTE THERAPY FOR GLUCOCORTICOIDS - The present invention relates to a pharmaceutical composition comprising glucocorticoid (GC)-induced human monocytes, and optionally a pharmaceutically acceptable carrier. | 02-14-2013 |
20130037409 | ELECTROCHEMICAL PROCESSOR, USES THEREOF AND METHOD OF COMPOSING THE ELECTROCHEMICAL PROCESSOR - The present invention is related to an electrochemical processor, which comprises two electrodes of different electrochemical potential, which are bridged via an electrolyte. Upon, completion of the electric circuit between the two electrodes, the second electrode is oxidized and therefore changed in at least one physical parameter, e.g. the second electrode becomes transparent. The electrochemical processor is characterized in that the surface of the second electrode, which is in contact with the electrolyte, is partially covered with an electrically insulating material, wherein this material is adjacent to the electrolyte. Moreover, the present invention relates to the use of this electrochemical processor and a method of composing such electrochemical processor. | 02-14-2013 |
20130012715 | PYRAZOLE SYNTHESIS BY COUPLING OF CARBOXYLIC ACID DERIVATIVES AND ENAMINES - The invention describes a novel process for synthesizing pyrazoles by means of oxidative conversion of enamines with suitable N-containing carboxylic acid derivatives. | 01-10-2013 |
20120036600 | METHOD FOR GENERATING HYPOALLERGENIC GLYCOPROTEINS IN MUTATED OR TRANSGENIC PLANTS OR PLANT CELLS, AND MUTATED OR TRANSGENIC PLANTS AND PLANT CELLS FOR GENERATING HYPOALLERGENIC GLYCOPROTEINS - Method for providing a hypoallergenic glycoprotein includes growing at least one of a mutated plant, a part of the mutated plant, plant cells produced from the mutated plant, a transgenic plant, a part of the transgenic plant and plant cells produced from the transgenic plant wherein an activity of an enzyme Golgi α-mannosidase II has been eliminated or decreased so as to obtain a grown material. The hypoallergenic glycoprotein is isolated from the grown material. | 02-09-2012 |
20110225663 | METHOD FOR PRODUCING EUKARYOTIC ORGANISMS WITH ENHANCED PATHOGEN RESISTANCE AND/OR RESISTANCE TO STRESS AND EUKARYOTIC TRANSGENIC ORGANISMS WITH ENHANCED PATHOGEN RESISTANCE AND/OR RESISTANCE TO STRESS - A method for producing an eukaryotic organism having at least one of enhanced pathogen resistance and resistance to stress includes expressing in a cytosol of the eukaryotic organism a glucose-6-phosphate dehydrogenase with an increased NADPH tolerance compared to an endogenous cytosolic glucose-6-phosphate dehydrogenase and at least one of reducing, eliminating and suppressing an activity of the endogenous cytosolic glucose-6-phosphate dehydrogenase. | 09-15-2011 |
20110047657 | METHOD FOR GENERATING HYPOALLERGENIC GLYCOPROTEINS IN MUTATED OR TRANSGENIC PLANTS OR PLANT CELLS, AND MUTATED OR TRANSGENIC PLANTS AND PLANT CELLS FOR GENERATING HYPOALLERGENIC GLYCOPROTEINS - Method for providing a hypoallergenic glycoprotein includes growing at least one of a mutated plant, a part of the mutated plant, plant cells produced from the mutated plant, a transgenic plant, a part of the transgenic plant and plant cells produced from the transgenic plant wherein an activity of an enzyme Golgi α-mannosidase II has been eliminated or decreased so as to obtain a grown material. The hypoallergenic glycoprotein is isolated from the grown material. | 02-24-2011 |
20100310633 | CHITINOSANASE - A chitinosanase obtainable from the fungus | 12-09-2010 |